Innovation at Avantor

In the race to treat and cure disease, there is no room for error, and no time for delays. See our commitment to cell & gene therapy production in action.

Watch now

Highlights

Avantor welcomes Emmanuel Ligner as its new President and CEO, an experienced leader with a strong track record of driving growth and value creation across the life sciences industry.

Accelerating Possibilities

See how we’re expanding our legacy, five years after becoming a public company.

Tola Olorunnisola, SVP and GM of Services, discusses AI and automation's impact on biopharmaceutical labs and speeding drug development with Technology Networks.

Read about our progress in reducing our carbon footprint, and how we’re supporting our customers and suppliers on their sustainability journeys.

Featured content

Key considerations for viral vector production

A holistic view of viral vector manufacturing for gene therapies.

Downstream process enhancements for mAbs manufacturing

Advancing the molecule to production.